Bard1 Life Sciences Limited (ASX:BD1)
Share Price and News
The company is under health care sector and was founded in 1991. The headquarter of the company is situated in Roberts Road, Subiaco, Australia. BD1 is into commercializing and developing a blood test for lung cancer detection. BARD1 Ribonucleic Acid (RNA) Test and BARD1 Ovarian Cancer Test are also in its pipeline.